| pubmed-article:11509277 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11509277 | lifeskim:mentions | umls-concept:C0010055 | lld:lifeskim |
| pubmed-article:11509277 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:11509277 | lifeskim:mentions | umls-concept:C1305957 | lld:lifeskim |
| pubmed-article:11509277 | lifeskim:mentions | umls-concept:C1514307 | lld:lifeskim |
| pubmed-article:11509277 | lifeskim:mentions | umls-concept:C1518988 | lld:lifeskim |
| pubmed-article:11509277 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:11509277 | pubmed:dateCreated | 2001-8-17 | lld:pubmed |
| pubmed-article:11509277 | pubmed:abstractText | Cardiac Troponin I (cTnI) is a well-known marker for myocardial damage in patients undergoing aorto-coronary bypass grafting (CABG) peaking 6-8 h after aortic declamping. The aim of this study was to evaluate cTnI release in the course of CABG procedures early, i.e. after the cessation of cardiopulmonary bypass (CPB) in order to recognize unstable cardiac function leading to hemodynamic deterioration and resulting in an adverse outcome (AO). AO is defined as the onset of myocardial infarction and/or death peri/postoperatively. | lld:pubmed |
| pubmed-article:11509277 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11509277 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11509277 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11509277 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11509277 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11509277 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11509277 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:11509277 | pubmed:issn | 1010-7940 | lld:pubmed |
| pubmed-article:11509277 | pubmed:author | pubmed-author:EigelPP | lld:pubmed |
| pubmed-article:11509277 | pubmed:author | pubmed-author:WagenpfeilSS | lld:pubmed |
| pubmed-article:11509277 | pubmed:author | pubmed-author:van IngenGG | lld:pubmed |
| pubmed-article:11509277 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11509277 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:11509277 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11509277 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11509277 | pubmed:pagination | 544-9 | lld:pubmed |
| pubmed-article:11509277 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:11509277 | pubmed:meshHeading | pubmed-meshheading:11509277... | lld:pubmed |
| pubmed-article:11509277 | pubmed:meshHeading | pubmed-meshheading:11509277... | lld:pubmed |
| pubmed-article:11509277 | pubmed:meshHeading | pubmed-meshheading:11509277... | lld:pubmed |
| pubmed-article:11509277 | pubmed:meshHeading | pubmed-meshheading:11509277... | lld:pubmed |
| pubmed-article:11509277 | pubmed:meshHeading | pubmed-meshheading:11509277... | lld:pubmed |
| pubmed-article:11509277 | pubmed:meshHeading | pubmed-meshheading:11509277... | lld:pubmed |
| pubmed-article:11509277 | pubmed:meshHeading | pubmed-meshheading:11509277... | lld:pubmed |
| pubmed-article:11509277 | pubmed:meshHeading | pubmed-meshheading:11509277... | lld:pubmed |
| pubmed-article:11509277 | pubmed:meshHeading | pubmed-meshheading:11509277... | lld:pubmed |
| pubmed-article:11509277 | pubmed:meshHeading | pubmed-meshheading:11509277... | lld:pubmed |
| pubmed-article:11509277 | pubmed:meshHeading | pubmed-meshheading:11509277... | lld:pubmed |
| pubmed-article:11509277 | pubmed:meshHeading | pubmed-meshheading:11509277... | lld:pubmed |
| pubmed-article:11509277 | pubmed:meshHeading | pubmed-meshheading:11509277... | lld:pubmed |
| pubmed-article:11509277 | pubmed:meshHeading | pubmed-meshheading:11509277... | lld:pubmed |
| pubmed-article:11509277 | pubmed:meshHeading | pubmed-meshheading:11509277... | lld:pubmed |
| pubmed-article:11509277 | pubmed:meshHeading | pubmed-meshheading:11509277... | lld:pubmed |
| pubmed-article:11509277 | pubmed:meshHeading | pubmed-meshheading:11509277... | lld:pubmed |
| pubmed-article:11509277 | pubmed:meshHeading | pubmed-meshheading:11509277... | lld:pubmed |
| pubmed-article:11509277 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11509277 | pubmed:articleTitle | Predictive value of perioperative cardiac troponin I for adverse outcome in coronary artery bypass surgery. | lld:pubmed |
| pubmed-article:11509277 | pubmed:affiliation | Department of Cardiac Surgery, Passau General Hospital, 94032, Passau, Germany. eigel@fmi.uni-passau.de | lld:pubmed |
| pubmed-article:11509277 | pubmed:publicationType | Journal Article | lld:pubmed |
